Niraparib-related severe refractory thrombocytopenia in ovarian cancer patients receiving paclitaxel/carboplatin chemotherapy: A report on three cases
Int. Journal of Clinical Pharmacology and Therapeutics · 2025
DOI: 10.5414/cp204724 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Mingtao Chen und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Piperidines, Ovarian Neoplasms, Thrombocytopenia, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Chen, M., Zhou, L., Yang, H., & Wang, M. (2025). Niraparib-related severe refractory thrombocytopenia in ovarian cancer patients receiving paclitaxel/carboplatin chemotherapy: A report on three cases. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204724
Vancouver
Chen M, Zhou L, Yang H, Wang M. Niraparib-related severe refractory thrombocytopenia in ovarian cancer patients receiving paclitaxel/carboplatin chemotherapy: A report on three cases. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204724
BibTeX
@article{Chen2025,
author = {Chen, Mingtao and Zhou, Lin and Yang, Huijuan and Wang, Mengmeng},
title = {Niraparib-related severe refractory thrombocytopenia in ovarian cancer patients receiving paclitaxel/carboplatin chemotherapy: A report on three cases},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.5414/cp204724}
}
EUVIMED